Bollard Group LLC Grows Position in Abbott Laboratories (NYSE:ABT)

Bollard Group LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 97,911 shares of the healthcare product maker’s stock after buying an additional 5,638 shares during the quarter. Bollard Group […]

Related Keywords

Canada ,Roberte Funck ,Lisad Earnhardt ,Raymond James ,Signature Resources Capital Management ,Abbott Laboratories ,Goldman Sachs Group ,Wealth Management Group ,Citigroup ,Bollard Group ,Rise Advisors ,Cornerstone Planning Group ,Royal Bank ,Stuart Chaussee Associates Inc ,Securities Exchange Commission ,Free Report ,Resources Capital Management ,Planning Group ,Private Wealth Management Group ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Abbott Laboratories Daily ,